EXPERIENCE WITH DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION IN A TERTIARY HEALTH FACILITY IN PORT HARCOURT, NIGERIA

Clinical experience with depot med Roxy progesterone acetate (DMPA) at the family planning clinic of the University of Port Harcourt Teaching Hospital between 1st of January 2004 and 31st of December 2013 is presented. This was a descriptive retrospective study aimed at establishing the acceptance, safety and effectiveness in our population. Information on socio-demographic characteristics, source of primary information, complications and accidental pregnancies were obtained from clients. Case files entered into Microsoft excel and analyzed using SPSS for Windows 15.0. Of the 3258 new contraceptive acceptors, 1064(32.66%) used DMPA; making it the most sort after contraceptive method in Port Harcourt. The modal age group of the clients was 30-34(36.84%). While most of the clients had secondary level of education (53.67%) majority of them got their information from health personnel (67.29%). Amenorrhoea was the most common complaint (63.29%). No accidental pregnancy occurred. DMPA is safe, effective and most accepted method of contraception in Port Harcourt. Concerted effort should be made in improving information dissemination on DMPA especially to the rural/non- literate population.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-03-02
DOI
https://doi.org/10.5281/zenodo.18833270
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EXPERIENCE WITH DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION IN A TERTIARY HEALTH FACILITY IN PORT HARCOURT, NIGERIA

Blessing Ifunanya Nwankwo
Zenodo (CERN European Organization for Nuclear Research)
Reproductive Health and Contraception
article

EXPERIENCE WITH DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION IN A TERTIARY HEALTH FACILITY IN PORT HARCOURT, NIGERIA

Blessing Ifunanya Nwankwo
article en

Abstract

Clinical experience with depot med Roxy progesterone acetate (DMPA) at the family planning clinic of the University of Port Harcourt Teaching Hospital between 1st of January 2004 and 31st of December 2013 is presented. This was a descriptive retrospective study aimed at establishing the acceptance, safety and effectiveness in our population. Information on socio-demographic characteristics, source of primary information, complications and accidental pregnancies were obtained from clients. Case files entered into Microsoft excel and analyzed using SPSS for Windows 15.0. Of the 3258 new contraceptive acceptors, 1064(32.66%) used DMPA; making it the most sort after contraceptive method in Port Harcourt. The modal age group of the clients was 30-34(36.84%). While most of the clients had secondary level of education (53.67%) majority of them got their information from health personnel (67.29%). Amenorrhoea was the most common complaint (63.29%). No accidental pregnancy occurred. DMPA is safe, effective and most accepted method of contraception in Port Harcourt. Concerted effort should be made in improving information dissemination on DMPA especially to the rural/non- literate population.

Zenodo (CERN European Organization for Nuclear Research)
University of Port Harcourt Teaching Hospital (NG)
Good health and well-being
Openalex Percentile: Top 41%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EXPERIENCE WITH DEPOT MEDROXYPROGESTERONE ACETATE CONTRACEPTION IN A TERTIARY HEALTH FACILITY IN PORT HARCOURT, NIGERIA — Blessing Ifunanya Nwankwo · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS